Market research
DIVISLAB.NSE Divi's Laboratories Limited
NSE INR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 2T
- P/E ratio
- 87.45
- Analyst target
- 8292.482
- Dividend yield
- 0.0%
- Beta
- 0.22
Profile
Company facts
- Exchange
- NSE
- Currency
- INR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- INE361B01024
- Market cap
- 2T
- P/E ratio
- 87.45
- Analyst target
- 8292.482
- Dividend yield
- 0.0%
- Beta
- 0.22
About
About Divi's Laboratories Limited
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as astaxanthin, beta-carotene, lycopene, canthaxanthin, apocarotenal, and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the DIVISLAB.NSE discussion.
5 years, 5 months ago
Divi's Laboratories Limited is currently in a long term uptrend where the price is trading 23.0% above its 200 day moving average.
From a valuation standpoint, the stock is 215.4% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 15.1.
Divi's Laboratories Limited's total revenue rose by 21.9% to $17B since the same quarter in the previous year.
Its net income has increased by 31.1% to $5B since the same quarter in the previous year.
Finally, its free cash flow grew by 224.4% to $12B since the same quarter in the previous year.
Based on the above factors, Divi's Laboratories Limited gets an overall score of 4/5.